Safety of PSMA-Targeted Molecular Radioligand Therapy with (177)Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)
PSMA靶向分子放射性配体疗法(177Lu-PSMA-617)的安全性:前瞻性多中心II期试验RESIST-PC(NCT03042312)的结果
期刊:
影响因子:
doi:10.2967/jnumed.121.262543
Calais, Jeremie; Czernin, Johannes; Thin, Pan; Gartmann, Jeannine; Nguyen, Kathleen; Armstrong, Wesley R; Allen-Auerbach, Martin; Quon, Andrew; Bahri, Shadfar; Gupta, Pawan; Gardner, Linda; Dahlbom, Magnus; He, Beilei; Esfandiari, Rouzbeh; Ranganathan, David; Herrmann, Ken; Eiber, Matthias; Fendler, Wolfgang P; Delpassand, Ebrahim